ALPHAEON Corporation, a subsidiary of Strathspey Crown Holdings, has completed its acquisition of Clarion Medical Technologies for $55 million in a combination of cash and equity plus performance-based earnouts. Clarion, based in Canada, has more than 100 employees, 36 sales representatives and over 40 product licenses.
“We are excited to have Clarion join ALPHAEON,” said Robert E. Grant, CEO of ALPHAEON. “We view Clarion as a leading provider of lifestyle healthcare products in Canada and are thrilled to combine their products and experience with our platform.”